EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours von Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A.S., Metellus, P., Peters, S., Hong, Y.-K., Winkler, F., Schadendorf, D., van den Bent, M., Seoane, J., Stahel, R., Minniti, G., Wesseling, P., Weller, M., Preusser, M.

Volltext

Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI von da Silva, N. A., Lohmann, P., Fairney, J., Magill, A. W., Oros Peusquens, A.-M., Choi, C.-H., Stirnberg, R., Stoffels, G., Galldiks, N., Golay, X., Langen, K.-J., Jon Shah, N.

Volltext

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: Results of a prospective phase II study von Piroth, M.D., Pinkawa, M., Holy, R., Klotz, J., Schaar, S., Stoffels, G., Galldiks, N., Coenen, H.H., Kaiser, H.J., Langen, K.J., Eble, M.J.

Volltext

Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients von Abdulla, D.S., Ruge, M., Scheffler, M., Nogova, L., Koleczko, S., Persigehl, T., Grau, S., Drzezga, A., Kobe, C., Buettner, R., Galldiks, N., Wolf, J.

Volltext

Résection d’un méningiome récidivant de la base du crâne assisté par imagerie métabolique au 18F-FET-PET et acide 5-amino-lévulinique von Cornelius, J.F, Slotty, P.J, Stoffels, G, Galldiks, N, Langen, K.J, Steiger, H.J

Volltext

The Role of Radionuclide Diagnostic Methods in Neuro-Oncology von Skvortsova, T. Yu, Judov, N., Plotkin, M., Stoffels, G., Galldiks, N., Krasikova, R. N., Langen, K. J.

Volltext

18F-FET PET imaging following immunotherapy with DC vaccination in glioblastoma patients von Rapp, M., Stamtsis-Datsi, A., Felsberg, J., Galldiks, N., Langen, K.-J., Dorf, R., Sabel, M.

Volltext

Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation von Witsch, J., Galldiks, N., Bender, A., Kollmar, R., Bösel, J., Hobohm, C., Günther, A., Schirotzek, I., Fuchs, K., Jüttler, E.

Volltext

P16.17 F-18-FET PET IMAGING FOR DIAGNOSIS OF LATE PSEUDOPROGRESSION IN PATIENTS WITH HIGH-GRADE GLIOMAS von Kebir, S., Schafer, N., Mack, F., Schaub, C., Niessen, M., Stoffels, G., Galldiks, N., Langen, K., Glas, M., Herrlinger, U.

Volltext

O7.05 DIFFERENTIATION OF LOCAL RECURRENT BRAIN METASTASIS FROM RADIATION-INDUCED CHANGES USING O-(2-[18F]FLUOROETHYL)-L-TYROSINE PET von Galldiks, N., Ruge, M. I., Hamisch, C., Stoffels, G., Ceccon, G., Rapp, M., Sabel, M., Langen, K.

Volltext

Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen von Galldiks, N., Ullrich, R., Schroeter, M., Fink, G. R., Kracht, L. W.

Volltext

Immuntherapie und zielgerichtete Therapie von Gliomen von Werner, J.-M., Ceccon, G., Fink, G. R., Galldiks, N.

Volltext

P16.10 DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET von Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Kebir, S., Goldbrunner, R., Ruge, M. I., Schmidt, M., Langen, K.

Volltext

P17.76 LOW-DOSE RATE STEREOTACTIC IODINE-125 BRACHYTHERAPY FOR THE TREATMENT OF INOPERABLE PRIMARY AND RECURRENT GLIOBLASTOMA: SINGLE-CENTER EXPERIENCE WITH 201 CASES von Kickingereder, P., Hamisch, C., Suchorska, B., Galldiks, N., Visser-Vandewalle, V., Goldbrunner, R., Kocher, M., Treuer, H., Voges, J., Ruge, M. I.

Volltext

The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma von Galldiks, Norbert, Stoffels, Gabriele, Filss, Christian, Rapp, Marion, Blau, Tobias, Tscherpel, Caroline, Ceccon, Garry, Dunkl, Veronika, Weinzierl, Martin, Stoffel, Michael, Sabel, Michael, Fink, Gereon R, Shah, Nadim J, Langen, Karl-Josef

Volltext

Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson's disease von Burghaus, L, Hilker, R, Thiel, A, Galldiks, N, Lehnhardt, F G, Zaro-Weber, O, Sturm, V, Heiss, W-D

Volltext

P09.12.B INFLUENCE OF PATIENT CHARACTERISTICS AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY ON FET UPTAKE IN THE REFERENCE REGION IN PATIENTS WITH GLIOMAS von Ceccon, G S, Wollring, M, Stetter, I, Werner, J, Lohmann, P, Fink, G R, Langen, K, Galldiks, N

Volltext

P18.08.A CCNU/TMZ IN ELDERLY PATIENTS WITH MGMT-METHYLATED GLIOBLASTOMA: A MULTICENTRIC RETROSPECTIVE COHORT von Weller, J, Zeyen, T, Schäfer, N, Hau, P, Glas, M, Werner, J, Galldiks, N, Seidel, C, Kowalski, T, Schaub, C, Sabel, M, Drexler, R, Schneider, M, Herrlinger, U

Volltext

OS05.6.A RADIOLOGICAL TREATMENT-ASSOCIATED CHANGES IN GLIOBLASTOMAS WITH OR WITHOUT AN MGMT PROMOTER-METHYLATION TREATED WITH CILENGITIDE: REVIEW OF THE EORTC CENTRIC AND CORE STUD... von Flies, C M, Friedrich, M, Lohmann, P, van Garderen, K, Smits, M, Tonn, J C, Weller, M, Galldiks, N, Snijders, T J

Volltext

P18.02.B ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING CONCOMITANT RADIOTHERAPY WITH TEMOZOLOMIDE USING FET PET IN PATIENTS WITH GLIOBLASTOMA von Stetter, I, Werner, J, Wollring, M, Ceccon, G, Lohmann, P, Stoffels, G, Mottaghy, F M, Fink, G R, Langen, K, Galldiks, N

Volltext